![]() |
![]() You are here : Home >
Businesses >
Pharmaceuticals and Life Sciences
Products and Services > Pharmaceutical Products > Speciality
Pharmaceuticals
Under Speciality Pharmaceuticals
the Company offers niche products like Radiophramceuticals and
Allergenic Extracts.
Radiopharmaceuticals DRAXIMAGE, the radiopharmaceutical division of Draxis, a subsidiary of Jubilant Organosys, develops, manufactures and markets innovative diagnostic imaging radiopharmaceutical solutions and therapeutic radiopharmaceutical products for the global market. The application of these products extends to cardiology, oncology, thyroid uptake and scan, lung scan, kidney imaging, brain imaging, bone scan etc. Draxis is the major supplier of lyophilised radiopharmaceutical kits for use with Technetium-99m including DRAXIMAGE MAA, MDP, DTPA, Glucoheptonate and Sestamibi. Draximage I131 products are the market leader in the US with more than 70% market share. I131 products are currently the major revenue driver. Product portfolio
Click here to know more on more about Draxis Image Allergenic Extracts HollisterStier Allergy, located in Spokane, Washington, USA, is a subsidiary of Jubilant Organosys. It is a world leader in the manufacturing of allergenic extracts targeted primarily at treating allergies and asthma. It is one of the leading North American immunotherapy companies with around 90 years of experience and brand loyalty. HollisterStier Allergy is a full service provider to the allergy speciality with a product range of over 200 different allergens and standard mixes of allergy vaccines. Products like the Venom line, diagnostic set and allergenic extracts, AP extracts, QUINTIP & ComforTen diagnostic skin test devices makes Allergy business stand out as a leader in the industry. Allergenic Extracts
|
|
Home | about Us | Businesses | Innovation | Investors | Sustainability | Media Center | Careers | Contact Us |
| Site Map | Privacy Policy | Disclaimer |
© Copyright Jubilant Organosys. All rights
reserved. |
This site is best viewed in 800 x 600 and above, IE 5.0+ |